Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Etofylline clofibrate

Copy Product Info
😃Good
Catalog No. T15256Cas No. 54504-70-0

Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.

Etofylline clofibrate

Etofylline clofibrate

Copy Product Info
😃Good
Catalog No. T15256Cas No. 54504-70-0
Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$485 days5 days
5 mg$765 days5 days
1 mL x 10 mM (in DMSO)$1075 days5 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.
In vivo
Etofylline clofibrate administered orally at a dosage of 12 mg/kg demonstrates a moderate initial efficacy with a 12% reduction in disaggregation time from a single dose. The effectiveness of the compound increases significantly with consistent daily usage, achieving a maximum reduction in disaggregation time of 31% after 5 days and 43% after 7 days of consecutive applications.
Chemical Properties
Molecular Weight420.85
FormulaC19H21ClN4O5
Cas No.54504-70-0
SmilesCn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O
Relative Density.1.37g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 52 mg/mL (123.56 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (5.94 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3761 mL11.8807 mL23.7614 mL118.8072 mL
5 mM0.4752 mL2.3761 mL4.7523 mL23.7614 mL
10 mM0.2376 mL1.1881 mL2.3761 mL11.8807 mL
20 mM0.1188 mL0.5940 mL1.1881 mL5.9404 mL
50 mM0.0475 mL0.2376 mL0.4752 mL2.3761 mL
100 mM0.0238 mL0.1188 mL0.2376 mL1.1881 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Etofylline clofibrate | purchase Etofylline clofibrate | Etofylline clofibrate cost | order Etofylline clofibrate | Etofylline clofibrate chemical structure | Etofylline clofibrate in vivo | Etofylline clofibrate formula | Etofylline clofibrate molecular weight